Elizabeth Anderson CFA
Stock Analyst at Evercore ISI
(3.38)
# 2,379
Out of 5,004 analysts
602
Total ratings
50.5%
Success rate
2.3%
Average return
Main Sectors:
Stocks Rated by Elizabeth Anderson CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Reiterated: Buy | $320 → $330 | $292.84 | +12.69% | 34 | Sep 25, 2026 | |
| MCK McKesson | Reiterated: Buy | $1,000 | $866.64 | +15.39% | 32 | Sep 15, 2026 | |
| WAY Waystar Holding | Reiterated: Buy | $28 | $24.70 | +13.36% | 18 | Sep 15, 2026 | |
| UNH UnitedHealth Group | Reiterated: Buy | $400 → $480 | $376.59 | +27.46% | 5 | Sep 14, 2026 | |
| LH Labcorp Holdings | Reiterated: Buy | $340 | $309.64 | +9.80% | 17 | Sep 11, 2026 | |
| OMDA Omada Health | Reiterated: Buy | $25 | $19.66 | +27.16% | 12 | Sep 11, 2026 | |
| CI The Cigna Group | Initiated Coverage: Hold | $290 | $272.01 | +6.61% | 1 | Sep 9, 2026 | |
| COR Cencora | Reiterated: Buy | $350 | $306.92 | +14.04% | 29 | Aug 13, 2026 | |
| GMRS GMR Solutions | Reiterated: Buy | $20 | $11.06 | +80.83% | 2 | Aug 13, 2026 | |
| CAH Cardinal Health | Reiterated: Buy | $240 → $270 | $220.22 | +22.60% | 32 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $185 → $275 | $270.37 | +1.71% | 22 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $220 | $146.78 | +49.88% | 46 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $22 → $40 | $26.35 | +51.80% | 32 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $14 | $9.40 | +48.94% | 29 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 → $125 | $80.73 | +54.84% | 18 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 → $125 | $89.13 | +40.24% | 38 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 → $39 | $34.70 | +12.39% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $32 | $23.95 | +33.61% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $32 | $19.71 | +62.35% | 18 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $105 | $95.57 | +9.87% | 9 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 → $105 | $86.38 | +21.56% | 28 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $25 | $19.89 | +25.69% | 24 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $220 | $172.33 | +27.66% | 23 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $7.5 | $6.09 | +23.15% | 30 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $250 → $480 | $397.93 | +20.62% | 9 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $360 | $396.09 | -9.11% | 3 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $210 | $236.32 | -11.14% | 19 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $1.74 | +72.41% | 23 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $8.5 | $0.7556 | n/a | 8 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.5 → $3 | $0.40 | n/a | 7 | May 6, 2022 |
Charles River Laboratories International
Sep 25, 2026
Reiterated: Buy
Price Target: $320 → $330
Current: $292.84
Upside: +12.69%
McKesson
Sep 15, 2026
Reiterated: Buy
Price Target: $1,000
Current: $866.64
Upside: +15.39%
Waystar Holding
Sep 15, 2026
Reiterated: Buy
Price Target: $28
Current: $24.70
Upside: +13.36%
UnitedHealth Group
Sep 14, 2026
Reiterated: Buy
Price Target: $400 → $480
Current: $376.59
Upside: +27.46%
Labcorp Holdings
Sep 11, 2026
Reiterated: Buy
Price Target: $340
Current: $309.64
Upside: +9.80%
Omada Health
Sep 11, 2026
Reiterated: Buy
Price Target: $25
Current: $19.66
Upside: +27.16%
The Cigna Group
Sep 9, 2026
Initiated Coverage: Hold
Price Target: $290
Current: $272.01
Upside: +6.61%
Cencora
Aug 13, 2026
Reiterated: Buy
Price Target: $350
Current: $306.92
Upside: +14.04%
GMR Solutions
Aug 13, 2026
Reiterated: Buy
Price Target: $20
Current: $11.06
Upside: +80.83%
Cardinal Health
Aug 12, 2026
Reiterated: Buy
Price Target: $240 → $270
Current: $220.22
Upside: +22.60%
Aug 12, 2026
Reiterated: Buy
Price Target: $185 → $275
Current: $270.37
Upside: +1.71%
Aug 10, 2026
Reiterated: Buy
Price Target: $220
Current: $146.78
Upside: +49.88%
Aug 7, 2026
Reiterated: Hold
Price Target: $22 → $40
Current: $26.35
Upside: +51.80%
Aug 7, 2026
Reiterated: Hold
Price Target: $13 → $14
Current: $9.40
Upside: +48.94%
Aug 6, 2026
Reiterated: Hold
Price Target: $32 → $125
Current: $80.73
Upside: +54.84%
Aug 6, 2026
Reiterated: Buy
Price Target: $105 → $125
Current: $89.13
Upside: +40.24%
Aug 6, 2026
Reiterated: Buy
Price Target: $48 → $39
Current: $34.70
Upside: +12.39%
Aug 6, 2026
Reiterated: Buy
Price Target: $33 → $32
Current: $23.95
Upside: +33.61%
Aug 6, 2026
Reiterated: Buy
Price Target: $26 → $32
Current: $19.71
Upside: +62.35%
Aug 4, 2026
Reiterated: Buy
Price Target: $45 → $105
Current: $95.57
Upside: +9.87%
Aug 4, 2026
Reiterated: Buy
Price Target: $90 → $105
Current: $86.38
Upside: +21.56%
Jul 30, 2026
Reiterated: Buy
Price Target: $14 → $25
Current: $19.89
Upside: +25.69%
Jul 30, 2026
Reiterated: Buy
Price Target: $220
Current: $172.33
Upside: +27.66%
Jul 30, 2026
Reiterated: Hold
Price Target: $6 → $7.5
Current: $6.09
Upside: +23.15%
Jul 29, 2026
Upgraded: Buy
Price Target: $250 → $480
Current: $397.93
Upside: +20.62%
May 19, 2026
Upgraded: Buy
Price Target: $360
Current: $396.09
Upside: -9.11%
Apr 20, 2026
Reiterated: Hold
Price Target: $210
Current: $236.32
Upside: -11.14%
Mar 30, 2026
Reiterated: Hold
Price Target: $3
Current: $1.74
Upside: +72.41%
Aug 9, 2022
Reiterated: Hold
Price Target: $9 → $8.5
Current: $0.7556
Upside: n/a
May 6, 2022
Reiterated: Hold
Price Target: $2.5 → $3
Current: $0.40
Upside: n/a